Key points
- Sales revenue increased by 30% to $23.9m
- Gross profit grew 33% to $14.9m
- Net profit after tax surged to $3.6m
Full summary
Biome Australia Ltd reported a strong financial performance for the year ended 30 June 2026, with sales revenue rising 30% to $23.9 million, gross profit increasing 33% to $14.9 million, and net profit after tax reaching $3.6 million. The company's flagship product, Biome Daily, became the number one probiotic in Australian pharmacies. Additionally, Biome signed a binding manufacturing agreement with Specialty Probiotics Australia and secured new distribution partnerships in Canada and Ireland. The company also recognized a deferred tax asset of $2.4 million for the first time, which significantly improved its earnings per share.
Guidance
Net profit after tax $3.6m for FY26
Outlook
Biome is well-positioned for continued growth in FY27, with new manufacturing and distribution agreements in place. The company aims to leverage its strong financial position and expand its market presence.